Pfizer Needs The Seagen Deal (NYSE:PFE)

Yossakorn Kaewwannarat

Pfizer Inc. (NYSE:PFE) got a big sales boost from the COVID-19 vaccine, and the end of the pandemic has cut off a big revenue stream. The biotech faces a year with a substantial revenue hit, while the company

Seagen Earnings estimates table

Source: Seeking Alpha

Seagen, Merck and Pfizer PS ratio
Data by YCharts

COVID-19 US vaccines

Source: Pfizer Q4’22 presentation

Author: jeserje

Leave a Reply

Your email address will not be published. Required fields are marked *